NCT00269061 Study In Patients With Type 2 Diabetes Who Are Taking Metformin And Sulfonylurea, Metformin And Insulin, Or Insulin Status COMPLETED Phase PHASE1
NCT00268983 Comparison Of Rituximab Versus Tositumomab and Iodine I 131 Tositumomab (BEXXAR® Therapeutic Regimen) For Patients With Relapsed Follicular Non-Hodgkins Lymphoma Status COMPLETED Phase PHASE3
NCT00268216 Survival Of Subjects With Chronic Obstructive Pulmonary Disease (COPD) Status COMPLETED Phase PHASE3
NCT00268203 Expanded Access Study Of BEXXAR® For Low Grade And Transformed Low-Grade Non-Hodgkin's Lymphoma Status COMPLETED Phase PHASE2
NCT00268177 Airway Inflammation In Patients With Chronic Obstructive Pulmonary Disease Status COMPLETED Phase PHASE3
NCT00267488 Intravenous Weekly Topotecan In Subjects With Recurrent Or Persistent Endometrial Cancer Status COMPLETED Phase PHASE2
NCT00265148 Brain Imaging Study Of Rosiglitazone Efficacy And Safety In Alzheimer's Disease Status COMPLETED Phase PHASE2
NCT00264680 Spanish Validation Of Quality of Life Questionnaire (QOLIE-10) For Epilepsy Status COMPLETED Phase N/A
NCT00264615 Patients With Epilepsy Taking LAMICTAL Immediate-Release Who Switch To Extended-Release Formulation And Vice Versa Status COMPLETED Phase PHASE3
NCT00263744 Study to Evaluate the Safety and Immunogenicity of MEDI-517P in Healthy Adult Female Volunteers Who Are HPV-16 or HPV-18 DNA Positive Status COMPLETED Phase PHASE1/PHASE2
NCT00263692 Comparison of GSK Biologicals' DTaP-IPV Candidate Vaccine to DTaP and IPV Separately Administered Vaccines in Terms of Immune Response and Safety Status COMPLETED Phase PHASE2
NCT00263679 Assessment of GSK Biologicals' Tdap Candidate Vaccine Administered as a Booster (6th Dose) in Terms of Immunogenicity and Safety to Children and Adolescents Previously Vaccinated With Five Doses of an Acellular Pertussis-containing Vaccine. Status COMPLETED Phase PHASE3
NCT00263666 A Study of Safety, Reactogenicity and Immunogenicity of HRV Vaccine in HIV Infected Infants in South Africa Status COMPLETED Phase PHASE2